Socioeconomic Inequalities in Statin Adherence under Universal Coverage: Does Sex Matter?

Circulation: Cardiovascular Quality and Outcomes

Volumn 9, Issue 6, 2016, Pages 704-713

  Aarnio, Emma ^a,b   Martikainen, Janne ^b   Winn, Aaron N ^c   Huupponen, Risto ^a,e   Vahtera, Jussi ^a,f   Korhonen, Maarit J ^d,e,f  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c School of Public Health   (Finland)

^d UNC Hamner Institute for Drug Safety Sciences   (United States)

^e Drug Development and Therapeutics ^*  (United States)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

cardiovascular diseases; income; medication adherence; primary prevention; sex; socioeconomic position

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NITRIC ACID DERIVATIVE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FINLAND; HEALTH CARE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HIGHEST INCOME GROUP; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICATION COMPLIANCE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RESIDENTIAL AREA; SECONDARY PREVENTION; SOCIAL STATUS; UNEMPLOYMENT; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DRUG COST; ECONOMICS; INCOME; INSURANCE; MULTIVARIATE ANALYSIS; PRESCRIPTION; PROCEDURES; REGISTER; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICAL MODEL; TIME FACTOR;

AGED; CARDIOVASCULAR DISEASES; DRUG COSTS; DRUG PRESCRIPTIONS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FINLAND; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCOME; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PRIMARY PREVENTION; REGISTRIES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; UNIVERSAL COVERAGE;

EID: 84995974995     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.116.002728     Document Type: Article

References (42)

1. Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A, Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol 2009 6 712 722. doi: 10.1038/nrcardio.2009.163
2. Marshall IJ, Wang Y, Crichton S, McKevitt C, Rudd AG, Wolfe CD, The effects of socioeconomic status on stroke risk and outcomes. Lancet Neurol 2015 14 1206 1218. doi: 10.1016/S1474-4422(15)00200-8
3. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, Kunst AE, European Union Working Group on Socioeconomic Inequalities in Health Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008 358 2468 2481. doi: 10.1056/NEJMsa0707519
4. Hanley GE, Morgan S, Reid RJ, Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction. J Gen Intern Med 2011 26 1329 1335. doi: 10.1007/s11606-011-1799-1
5. Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, Davey-Smith G, Dennison-Himmelfarb CR, Lauer MS, Lockwood DW, Rosal M, Yancy CW, American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, and Stroke Council Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2015 132 873 898. doi: 10.1161/CIR.0000000000000228
6. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S, Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013 1 CD004816
7. Lemstra M, Blackburn D, Crawley A, Fung R, Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol 2012 28 574 580. doi: 10.1016/j.cjca.2012.05.007
8. Alsabbagh MH, Lemstra M, Eurich D, Lix LM, Wilson TW, Watson E, Blackburn DF, Socioeconomic status and nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Value Health 2014 17 288 296. doi: 10.1016/j.jval.2013.11.011
9. Wallach-Kildemoes H, Andersen M, Diderichsen F, Lange T, Adherence to preventive statin therapy according to socioeconomic position. Eur J Clin Pharmacol 2013 69 1553 1563. doi: 10.1007/s00228-013-1488-6
10. Rasmussen JN, Gislason GH, Rasmussen S, Abildstrom SZ, Schramm TK, Køber L, Diderichsen F, Osler M, Torp-Pedersen C, Madsen M, Use of statins and beta-blockers after acute myocardial infarction according to income and education. J Epidemiol Community Health 2007 61 1091 1097. doi: 10.1136/jech.2006.055525
11. Citarella A, Kieler H, Sundström A, Linder M, Wettermark B, Berglind IA, Andersen M, Family history of cardiovascular disease and influence on statin therapy persistence. Eur J Clin Pharmacol 2014 70 701 707. doi: 10.1007/s00228-014-1659-0
12. Alsabbagh MW, Lix LM, Eurich D, Wilson TW, Blackburn DF, Multiple-domain versus single-domain measurements of socioeconomic status (SES) for predicting nonadherence to statin medications: an observational population-based cohort study. Med Care 2016 54 195 204. doi: 10.1097/MLR.0000000000000468
13. Warren JR, Falster MO, Fox D, Jorm L, Factors influencing adherence in long-term use of statins. Pharmacoepidemiol Drug Saf 2013 22 1298 1307. doi: 10.1002/pds.3526
14. Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A, Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education. Br J Clin Pharmacol 2009 67 355 362. doi: 10.1111/j.1365-2125.2008.03360.x
15. Nagin DS, Odgers CL, Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 2010 6 109 138. doi: 10.1146/annurev.clinpsy.121208.131413
16. Modi AC, Rausch JR, Glauser TA, Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 2011 305 1669 1676. doi: 10.1001/jama.2011.506
17. Franklin JM, Shrank WH, Pakes J, Sanfélix-Gimeno G, Matlin OS, Brennan TA, Choudhry NK, Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care 2013 51 789 796. doi: 10.1097/MLR.0b013e3182984c1f
18. Franklin JM, Krumme AA, Tong AY, Shrank WH, Matlin OS, Brennan TA, Choudhry NK, Association between trajectories of statin adherence and subsequent cardiovascular events. Pharmacoepidemiol Drug Saf 2015 24 1105 1113. doi: 10.1002/pds.3787
19. Kilpi F, Silventoinen K, Konttinen H, Martikainen P, Disentangling the relative importance of different socioeconomic resources for myocardial infarction incidence and survival: a longitudinal study of over 300,000 Finnish adults. Eur J Public Health 2016 26 260 266. doi: 10.1093/eurpub/ckv202
20. Vehko T, Manderbacka K, Arffman M, Reunanen A, Keskimäki I, Increasing resources effected equity in access to revascularizations for patients with diabetes. Scand Cardiovasc J 2010 44 237 244. doi: 10.3109/14017431.2010.494309
21. Manderbacka K, Keskimäki I, Reunanen A, Klaukka T, Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. Int J Equity Health 2008 7 16. doi: 10.1186/1475-9276-7-16
22. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT, The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010 106 86 94. doi: 10.1111/j.1742-7843.2009.00494.x
23. World Health Organization (WHO) ATC/DDD index 2016. http://www.whocc.no/atc-ddd-index/. Accessed February 24, 2016
24. Peltola M, Juntunen M, Häkkinen U, Rosenqvist G, Seppälä TT, Sund R, A methodological approach for register-based evaluation of cost and outcomes in health care. Ann Med 2011 43 Suppl 1 S4 13. doi: 10.3109/07853890.2011.586364
25. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 25 suppl 2 S1 45. doi: 10.1161/01.cir.0000437738.63853.7a
26. Romppainen T, Rikala M, Aarnio E, Korhonen MJ, Saastamoinen LK, Huupponen R, Measurement of statin exposure in the absence of information on prescribed doses. Eur J Clin Pharmacol 2014 70 1275 1276. doi: 10.1007/s00228-014-1737-3
27. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M, A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007 10 3 12. doi: 10.1111/j.1524-4733.2006.00139.x
28. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC, Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009 25 2303 2310. doi: 10.1185/03007990903126833
29. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012 33 1635 1701. doi: 10.1093/eurheartj/ehs092
30. Jones BL, Nagin DS, Roeder K, A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 2001 29 374 393
31. Korhonen MJ, Halonen JI, Brookhart MA, Kawachi I, Pentti J, Karlsson H, Kivimäki M, Vahtera J, Childhood adversity as a predictor of non-adherence to statin therapy in adulthood. PLoS One 2015 10 e0127638. doi: 10.1371/journal.pone.0127638
32. Laaksonen M, Talala K, Martelin T, Rahkonen O, Roos E, Helakorpi S, Laatikainen T, Prättälä R, Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 years. Eur J Public Health 2008 18 38 43. doi: 10.1093/eurpub/ckm051
33. van der Heide I, Rademakers J, Schipper M, Droomers M, Sørensen K, Uiters E, Health literacy of Dutch adults: a cross sectional survey. BMC Public Health 2013 13 179. doi: 10.1186/1471-2458-13-179
34. Eriksson-Backa K, Ek S, Niemelä R, Huotari ML, Health information literacy in everyday life: a study of Finns aged 65-79 years. Health Informatics J 2012 18 83 94. doi: 10.1177/1460458212445797
35. Karalis DG, Wild RA, Maki KC, Gaskins R, Jacobson TA, Sponseller CA, Cohen JD, Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol 2016 10 833 841. doi: 10.1016/j.jacl.2016.02.016
36. Lemstra M, Blackburn D, Nonadherence to statin therapy: discontinuation after a single fill. Can J Cardiol 2012 28 567 573. doi: 10.1016/j.cjca.2012.03.018
37. Lahelma E, Martikainen P, Laaksonen M, Aittomäki A, Pathways between socioeconomic determinants of health. J Epidemiol Community Health 2004 58 327 332
38. Aaltonen K, Miettinen J, Airio I, Martikainen JE, Saastamoinen LK, Bell JS, Hartikainen S, Norris P, Cost-related barriers to use of health services and prescription medicines in Finland: a cross-sectional survey. Eur J Public Health 2015 25 368 372. doi: 10.1093/eurpub/cku176
39. Pottegård A, Christensen Rd, Houji A, Christiansen CB, Paulsen MS, Thomsen JL, Hallas J, Primary non-adherence in general practice: a Danish register study. Eur J Clin Pharmacol 2014 70 757 763. doi: 10.1007/s00228-014-1677-y
40. Official Statistics of Finland (OSF) Income distribution statistics 2012. Statistics Finland; 2014. www.stat.fi/til/tjt/2012/04/tjt-2012-04-2014-05-27-en.pdf. Accessed February 24, 2016
41. Amendment 1656/2015 to the Finnish Health Insurance Act 1224/2004. http://www.finlex.fi/fi/laki/ajantasa/2004/20041224 (available in Finnish only). Accessed February 24, 2016
42. Halava H, Westerlund H, Korhonen MJ, Pentti J, Kivimäki M, Kjeldgård L, Alexanderson K, Vahtera J, Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base. PLoS One 2015 10 e0130901. doi: 10.1371/journal.pone.0130901